GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Choate Investment Advisors

Choate Investment Advisors raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 14.6% in the fourth quarter, HoldingsChannel reports. The firm owned 3,714 shares of the company’s stock after acquiring an additional 472 shares during the period. Choate Investment Advisors’ holdings in GE HealthCare Technologies were worth $290,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently made changes to their positions in GEHC. Harbour Investments Inc. raised its position in shares of GE HealthCare Technologies by 4.3% during the 3rd quarter. Harbour Investments Inc. now owns 3,164 shares of the company’s stock worth $297,000 after buying an additional 131 shares in the last quarter. OneDigital Investment Advisors LLC raised its position in shares of GE HealthCare Technologies by 7.5% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 13,798 shares of the company’s stock worth $1,295,000 after buying an additional 961 shares in the last quarter. Empowered Funds LLC raised its position in shares of GE HealthCare Technologies by 30.7% during the 3rd quarter. Empowered Funds LLC now owns 23,470 shares of the company’s stock worth $2,203,000 after buying an additional 5,512 shares in the last quarter. Natixis Advisors LLC raised its position in shares of GE HealthCare Technologies by 36.7% during the 3rd quarter. Natixis Advisors LLC now owns 380,071 shares of the company’s stock worth $35,670,000 after buying an additional 102,000 shares in the last quarter. Finally, Mutual of America Capital Management LLC raised its position in shares of GE HealthCare Technologies by 5.0% during the 3rd quarter. Mutual of America Capital Management LLC now owns 56,349 shares of the company’s stock worth $5,288,000 after buying an additional 2,696 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Up 0.6 %

Shares of NASDAQ:GEHC opened at $82.47 on Tuesday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The company has a market cap of $37.71 billion, a PE ratio of 19.05, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80. The firm has a 50 day simple moving average of $87.27 and a 200 day simple moving average of $86.12.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. As a group, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Citigroup boosted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. The Goldman Sachs Group upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $98.75.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.